Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [7908]

Key enzyme discovered in breast cancer proliferation and treatment resistance

Key enzyme discovered in breast cancer proliferation and treatment resistance

An international study co-led by CNIO identifies a 'sensor' that activates cell migration

An international study co-led by CNIO identifies a 'sensor' that activates cell migration

Last couple of months in Oncology with Dr. Bishal Gyawali: March 2019

Last couple of months in Oncology with Dr. Bishal Gyawali: March 2019

New ESMO guidelines include tivozanib recommendation for patients with advanced renal cell carcinoma

New ESMO guidelines include tivozanib recommendation for patients with advanced renal cell carcinoma

FDA approves atezolizumab for PD-L1 positive unresectable locally advanced or metastatic triple-negative breast cancer

FDA approves atezolizumab for PD-L1 positive unresectable locally advanced or metastatic triple-negative breast...

Researchers develop an innovative and more cost-effective method to make cancer drugs

Researchers develop an innovative and more cost-effective method to make cancer drugs

Why cancer most frequently spreads to the liver

Why cancer most frequently spreads to the liver

European approval for enzalutamide for adult men with high-risk non-metastatic castration-resistant prostate cancer

European approval for enzalutamide for adult men with high-risk non-metastatic castration-resistant prostate cancer

Genomic testing of a single patient reveals a gene commonly mutated in paediatric melanoma

Genomic testing of a single patient reveals a gene commonly mutated in paediatric melanoma

Olaparib receives positive EU CHMP opinion for use in germline BRCA-mutated HER2-negative advanced breast cancer

Olaparib receives positive EU CHMP opinion for use in germline BRCA-mutated HER2-negative advanced breast cancer

More from ecancer